Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

MVA-BN smallpox vaccine

A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:modified vaccinia Ankara - Bavarian Nordic smallpox vaccine
modified vaccinia Ankara smallpox vaccine
MVA smallpox vaccine
US brand name:Imvamune
Jynneos
Foreign brand name:Imvanex
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search